Full Press Release Details
New executives bring deep expertise to elevate quality and accelerate innovation across global operations
SAN DIEGO , July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL ) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has appointed two industry-leading executives to its leadership team. Devon Burek joins the Company as Senior Vice President of Global Quality, and Sergio Gadaleta joins as Senior Vice President of Clinical and Regulatory Affairs. These hires reflect the Company's continued investment in operational excellence, product quality and regulatory innovation to support global growth.